Vertex Pharmaceuticals | VRTX - Market Capitalization

Stock Price
465.61
Daily Change
-6.40 -1.36%
Monthly
3.75%
Yearly
-3.46%
Q1 Forecast
455.43

Vertex Pharmaceuticals reported $122.09B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
Amgen USD 184.41B 32.48B Feb/2026
Arrowhead Research USD 4.77B 2.59B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Incyte USD 16.56B 3.38B Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 293.38B 83.74B Feb/2026
Moderna USD 10.09B 581M Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025